Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.
about
The clinical use of structural MRI in Alzheimer diseaseA commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderlyRegulation of the Postsynaptic Compartment of Excitatory Synapses by the Actin Cytoskeleton in Health and Its Disruption in DiseaseSuspected non-Alzheimer disease pathophysiology--concept and controversyThe Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inceptionWhy looking at the whole hippocampus is not enough-a critical role for anteroposterior axis, subfield and activation analyses to enhance predictive value of hippocampal changes for Alzheimer's disease diagnosis.Prediction of cognitive decline in healthy older adults using fMRITraumatic brain injury, neuroimaging, and neurodegenerationFunctional magnetic resonance imaging of semantic memory as a presymptomatic biomarker of Alzheimer's disease riskLifestyle and genetic contributions to cognitive decline and hippocampal structure and function in healthy agingThe clinical value of large neuroimaging data sets in Alzheimer's diseaseThe Alzheimer's disease neuroimaging initiative: progress report and future plans3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI.Reducing hippocampal extracellular matrix reverses early memory deficits in a mouse model of Alzheimer's disease.MULTIMODAL CLASSIFICATION OF DEMENTIA USING FUNCTIONAL DATA, ANATOMICAL FEATURES AND 3D INVARIANT SHAPE DESCRIPTORS.Using structural and diffusion magnetic resonance imaging to differentiate the dementias.Advances in MRI biomarkers for the diagnosis of Alzheimer's disease.2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative.Quantitative structural MRI for early detection of Alzheimer's disease.Mapping Alzheimer's disease progression in 1309 MRI scans: power estimates for different inter-scan intervals.Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects.Mary S. Easton Center of Alzheimer's Disease Research at UCLA: advancing the therapeutic imperative.Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease.The power of neuroimaging biomarkers for screening frontotemporal dementia.Recent advances in imaging Alzheimer's disease.Differential putaminal morphology in Huntington's disease, frontotemporal dementia and Alzheimer's disease.Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study.3D maps localize caudate nucleus atrophy in 400 Alzheimer's disease, mild cognitive impairment, and healthy elderly subjectsVentricular maps in 804 ADNI subjects: correlations with CSF biomarkers and clinical declineRelationship between CSF biomarkers of Alzheimer's disease and rates of regional cortical thinning in ADNI data.The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scansLocalized hippocampus measures are associated with Alzheimer pathology and cognition independent of total hippocampal volumeNearly automatic segmentation of hippocampal subfields in in vivo focal T2-weighted MRIOptimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjectsEffects of ApoE4 and maternal history of dementia on hippocampal atrophyThe diffeomorphometry of regional shape change rates and its relevance to cognitive deterioration in mild cognitive impairment and Alzheimer's disease.
P2860
Q24609648-DCF95293-70E2-4230-8AB4-962961F79E04Q24631142-64DFFE1E-9F9D-4800-9B3D-B8F3B54BFB65Q26748973-045DE29D-14A0-411A-A042-C88901AAB807Q26771270-0CF80461-2A06-4656-BBF8-064B5CBFBDCCQ27006831-39D38708-CF98-4843-B498-62DF07C43C9DQ27692592-1BF37F82-9C5C-47DF-97AA-1680583F1FEFQ28383378-FF2C86D8-20C6-4D0D-B91E-B9C11030464FQ28386903-EF7CD3FA-6309-4734-9D84-756E8C70A8E1Q28394799-122BE4E1-CB95-44EE-95FF-6EAF4CA8F23DQ28395012-930F1A9B-4F98-46D1-8064-8E83EE7CE370Q28709465-E0F041F6-A279-4773-AE29-791BDDE337C6Q28749585-D40E7AC8-B7FF-4517-B860-C2A1B02A17FCQ30496583-7867A341-0245-4F2C-BAFD-8DE2D8AAFF33Q30586616-1F9CC21E-D23A-4790-AFC7-468ACB84B6C1Q30766514-FC725422-FDC3-41D0-895F-D235BC4B7CCDQ30836806-7FA1A3BF-C224-410E-B314-31F5C2F4C672Q30870223-6D8CBA0B-2CB0-4921-8707-CC5BA506CD49Q30971403-50E5B98D-8239-4F79-B78C-BB29EEABFC99Q30981669-A4FBF8B8-B8E6-4473-AEA5-02B27E8E055FQ33388073-16C79D07-8F8D-420C-9717-AC29ABD0C253Q33572446-8A9A62FE-23DF-4143-8C45-5B066260D120Q33729033-0E8B9C10-AE37-4191-AB6E-9AC76C5669E8Q33759240-D2FB3E1C-5F71-4BA8-A566-610E0BF8EC5CQ33759397-C5D5DBC3-CA7E-467C-BCC7-833EE4AB5625Q33794509-60C6B34E-C75B-49C9-BFB5-0A9186347A4BQ33798453-97545647-9266-47B6-9E26-7F1CEBFA035AQ33934175-198FABB3-B4A2-4513-A95A-361A793C9723Q33946440-1083AEAE-750E-43A2-9FCD-9C7BB902FA83Q33959500-3DFB975D-C77E-472A-AF64-FBA280516902Q33987747-93691F8D-2154-4759-BE17-794DD05D5DF0Q33990243-8A3E3417-521D-456B-BC20-0F7F8C5B65FDQ33997421-C0BE6670-37CD-4F76-8F92-9AE287B7309AQ34039952-463CBF0F-9442-4996-8307-5394E6F739C1Q34065449-0883FC52-8511-4BCC-962B-5AFC285B5A7CQ34081087-3822C946-60AE-4D22-9DF2-AC0591D04781Q34101122-05C470A6-AA3F-4557-8088-CEC6CB88A88CQ34126524-01DEEFF9-B8D1-4D01-93F7-3954FE513943Q34271896-4E5F31AE-FEDC-4130-916F-9A14BCF72E94Q34440832-60F3BAE2-8818-4CEA-BD63-E4BAB79666D1Q34460995-F61ABBAC-B460-427B-89C7-F1CE4FEEECEB
P2860
Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Automated 3D mapping of hippoc ...... airment, and elderly controls.
@en
Automated 3D mapping of hippoc ...... airment, and elderly controls.
@nl
type
label
Automated 3D mapping of hippoc ...... airment, and elderly controls.
@en
Automated 3D mapping of hippoc ...... airment, and elderly controls.
@nl
prefLabel
Automated 3D mapping of hippoc ...... airment, and elderly controls.
@en
Automated 3D mapping of hippoc ...... airment, and elderly controls.
@nl
P2093
P2860
P50
P356
P1433
P1476
Automated 3D mapping of hippoc ...... airment, and elderly controls.
@en
P2093
Christina Avedissian
Jonathan H Morra
Liana G Apostolova
Neelroop Parikshak
Norbert Schuff
Sarah K Madsen
Zhuowen Tu
P2860
P304
P356
10.1002/HBM.20708
P50
P577
2009-09-01T00:00:00Z